Tearon

Quick links to important sections

Tearon

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tearon

What is Tearon? Quick Facts and Identity

Tearon is a pharmaceutical preparation classified as a Synthetic Tear Substitute designed to provide relief from the symptoms of dry eyes. It is positioned for daily symptomatic relief, distinguished by its use of a dual-polymer hydration system rather than a single moisturizing agent.

Property Description
Active Ingredients Polyethylene Glycol (Macrogol), Propylene Glycol
Form Sterile Ophthalmic Solution (Eye Drops)
Pharmacological Class Ocular Lubricant, Humectant
Common Use Relief of ocular dryness, burning, and irritation
Origin Synthetic

Identity and Classification as an Ocular Lubricant

Tearon is a Sterile Ophthalmic Solution applied topically to the eye and is classified within the group of Ocular Lubricants. Its primary function is to serve as a Synthetic Tear Substitute, physically augmenting the natural tear film when tear production is insufficient or evaporation is excessive. This specific formulation, containing the combination of Macrogol and Propylene Glycol, is clinically recognized for improving the stability of the tear film in individuals experiencing chronic ocular dryness. This indicates the medicine works to stabilize the tear film and provide sustained moisture.


Composition: Macrogol, Propylene Glycol, and Synthetic Origin

The product's efficacy is based on its two active ingredients: Polyethylene Glycol (Macrogol) and Propylene Glycol. Both are entirely synthetic compounds known as humectants, integrated into an Aqueous Solution, making Tearon a Combination Product. The synergistic effect of these two polymers ensures greater lubrication and longer residency time on the ocular surface compared to many single-polymer formulations. This enhanced formulation supports its general therapeutic purpose: managing routine eye discomfort stemming from environmental factors, extensive screen use, or contact lens wear.

What side effects are possible with Tearon?

Possible Side Effects and Safety Information

The safety profile for Tearon, an ocular lubricant containing Polyethylene Glycol and Propylene Glycol, is primarily characterized by localized effects related to its topical application. Official regulatory documentation classifies most reported effects within the Eye Disorders system-organ class, reflecting the product's minimal systemic absorption.

Officially Documented Ocular Reactions

The most commonly noted adverse reactions are generally transient and occur at the site of application. While specific frequency categories (e.g., Common) are often not assigned in official U.S. labeling, the effects include temporary blurred vision and localized eye irritation (such as minor burning or stinging), which may be noticed upon initial use.


Serious Adverse Reactions and Discontinuation Criteria

Official labeling defines specific ocular signs that are considered serious and require the user to discontinue the product immediately. These mandated discontinuation criteria include:

  • Eye pain
  • Changes in vision
  • Redness or irritation of the eye(s) that persists or worsens for more than 72 hours.

Rarely, a very serious allergic reaction (Hypersensitivity) to any component of the formulation is documented in safety reports.


Population and Safety Restrictions

The primary safety restriction (contraindication) is a known sensitivity (allergy) to any ingredient in Tearon. Due to the lack of extensive specific human data for ophthalmic products of this type, regulatory documents typically advise consulting a health professional before use during pregnancy and lactation or for use in pediatric populations under a specified age.

Overdose and Emergency Response

Overdose and When to Seek Help

This section strictly documents the officially recognized manifestations of overdose and the mandatory emergency actions for Tearon, as stated in government regulatory sources. Overdose is primarily associated with either acute excessive topical application or accidental oral ingestion of the ophthalmic solution. Excessive topical use may result in transient ocular discomfort, temporary blurred vision, or increased lacrimation. These symptoms are typically localized and self-limiting, resolving upon discontinuation of the product.

Accidental oral ingestion of the bottle’s contents, particularly a large volume, represents the primary systemic exposure risk, though the potential for severe effects is officially documented as low. Ingestion may theoretically lead to non-severe gastrointestinal upset. Immediate medical attention must be sought following accidental oral ingestion of the solution, and contacting a Poison Control Center is a mandated emergency step.

Management of an overdose relies on symptomatic and supportive treatment, as no specific antidote is known. Hospital monitoring may be required in cases involving the ingestion of a large volume. If transient ocular symptoms from over-application persist or worsen after the product has been discontinued, consultation with a healthcare professional is required.

Therapeutic Uses of Tearon

Easing Discomfort from Dryness and Irritation

Tearon is commonly used to help with groups of symptoms that may appear suddenly or intensify over time, such as a gritty feeling, burning, or stinging. These types of products are applied in clinical settings that involve acute or unstable symptom patterns. Tearon is applied across domains where additional symptomatic support is needed, relevant in conditions where symptoms may intensify temporarily.


Support for Episodic and Functional Strain

Tearon is applied across domains where additional symptomatic support is needed, and is relevant for easing symptoms that interfere with daily comfort and may create noticeable physiological strain. It is used in situations involving recurrent or episodic manifestations, often used during phases when symptoms become more noticeable. Tearon is applied in addressing symptom clusters that may become intense or disruptive, helping to improve day-to-day comfort during symptomatic periods. It may help patients cope more steadily with symptom fluctuations.

“Tearon supports the patient during difficult episodes by easing overall discomfort related to temporary strain.”

Quick Fact: May assist with stinging

Tearon is considered relevant for easing symptoms related to irritative states and is commonly used across conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NHS guidance on Ocular Lubricants

Eligibility and Restrictions for Use

Eligibility Scope

Tearon is approved for use in Adults and Older Adults under standard labeled conditions for temporary dry eye relief.

The absolute contraindication for Tearon is a known hypersensitivity or allergy to Polyethylene Glycol, Propylene Glycol, or any other ingredient in the formulation.

Populations Requiring Restricted or Conditional Use

Official regulatory documents categorize several populations where use is limited or conditional:

  • Age-Related: Safety and effectiveness have not been established in children and infants. Use in patients under 6 years of age should only occur after consultation with a health professional.
  • Physiological Status: Individuals who are pregnant or breastfeeding must ask a healthcare professional before use. The eligibility status is conditional due to insufficient data regarding use during these periods.
  • Ocular Health: Use is not recommended if an active or severe eye infection is present, as the drops do not treat the underlying condition. Consultation is also advised for patients with recent or scheduled eye surgery.
  • Comorbidity: No specific restrictions are documented for individuals with renal or hepatic impairment.

Eligibility Classifications

Regulatory labeling classifies the risk of using Tearon based primarily on component allergy (Contraindicated) and age/physiological status (Conditional/Use Not Established).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Tearon (Polyethylene Glycol/Propylene Glycol Ophthalmic Solution) is constrained primarily to local, non-systemic administration requirements. Due to its topical ocular route and negligible systemic absorption, Tearon is not documented to cause systemic pharmacokinetic or pharmacodynamic drug-drug interactions.

Systemic Interaction Profile

Regulatory documents state that Tearon is not associated with interactions involving metabolic enzymes (such as CYP450), drug transporters, or altered systemic exposure (AUC/Cmax) of co-administered systemic medicines. Consequently, no formal contraindications, exposure-modifying restrictions, or warnings regarding interactions with food, alcohol, supplements, or herbal products are listed in the official labeling.

Administration-Timing Interaction

Tearon does possess a mandatory administration-timing restriction, classified as a local pharmacokinetic interaction, which applies when co-administering other eye products.

Interacting Product Category Official Restriction Type Requirement
Other Topical Ophthalmic Products (Drops/Ointments) Mandatory Timing Separation Apply Tearon at least five minutes after other products.

This rule is required by regulatory authorities to prevent the physical washout of the previously administered eye medication, ensuring the local efficacy of both products. Tearon must be the last product administered to the eye in a sequence.

Mechanism of Action

How Tearon Works: Pharmacodynamic Mechanism

Tearon exerts its pharmacological effect by engaging specific receptor targets within defined physiological systems. The drug functions primarily as a selective antagonist at these receptors, preventing the binding of endogenous signaling mediators.

This interaction initiates the mechanistic cascade by suppressing the receptor-mediated signaling sequences. At the molecular level, Tearon modifies multi-layered intracellular cascades and influences feedback regulation within those pathways. This action results in the modulation of overactive physiological responses, specifically by reducing the downstream activation associated with excessive mediator activity. The outcome is an alteration in pathway function, leading to a modified state within the targeted biological system.

Dosage and Administration Information

Administration Method

Tearon is an ophthalmic solution intended for topical use in the eyes. Proper administration technique is important to ensure the solution is applied effectively and to maintain the cleanliness of the product.

Preparation

Before applying the eye drops, hands should be washed thoroughly with soap and water. If wearing contact lenses, they should generally be removed prior to application unless otherwise specified by a healthcare professional.

Application Steps

  1. Tilt the head back slightly and look upward.
  2. Gently pull down the lower eyelid with one finger to create a small pocket.
  3. Hold the dropper bottle above the eye, ensuring the tip does not touch the eye, eyelashes, eyelids, or any other surface. Touching the tip can contaminate the solution.
  4. Release the prescribed number of drops into the pocket formed by the lower eyelid.
  5. Close the eye gently. Avoid blinking or squeezing the eyelids tightly.
  6. Apply light pressure to the inner corner of the eye (near the nose) for approximately one minute. This help prevents the liquid from draining into the tear duct.
  7. Repeat the process for the other eye if required.

Handling and Storage

The cap should be replaced immediately after use and tightened securely. The tip of the dropper must remain clean and should not come into contact with any surfaces. Store the bottle according to the temperature requirements indicated on the packaging, away from direct light and moisture. Keep the container tightly closed when not in use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Tearon

Research exploring this formulation's components (Polyethylene Glycol/Propylene Glycol) was initiated to investigate their use as a synthetic tear substitute. The evidence base describes what types of studies have been conducted, the types of patient experiences that were measured, and where research is still considered limited or ongoing.


Evidence for Use in Mild to Moderate Dry Eye Symptoms

Research for this formulation has largely involved Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews that focused on conditions characterized by fluctuating or episodic manifestations of dry eye symptoms. These trials were applied in research contexts involving patients diagnosed with mild to moderate dry eye disease (DED).

In these studies, research examined two main aspects: patient-reported outcomes describing perceived discomfort (such as dryness, burning, and the gritty sensation) and objective ocular signs, such as Tear Film Break-Up Time (TFBUT). Research reports describe measured changes in these outcomes observed during the study period related to the short-term evolution of both symptoms and signs in the observed populations. Research contributes to the ongoing evaluation of ocular lubricants.


Long-Term Studies and Follow-Up Data

When considering the duration of use, the primary evidence comes from studies where the follow-up durations were limited. Most key RCTs examining the formulation were conducted over short-term intervals, typically lasting up to three months.

There is limited information for long-term outcomes, meaning the patterns of using the formulation continuously over periods of six months or a year are not fully established. Research has explored short-term changes, but the evidence base does not provide extensive data to monitor the durability of symptom patterns over many months or years.


What is Still Uncertain About Tearon Research

Despite the existing research, there are recognized limitations and areas where certainty remains low. One key limitation is that evidence quality varies across studies, and while short-term data is available, the long-term effects are not fully established.

Research does not determine whether an individual will respond similarly to the group patterns observed in studies, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. NIH Clinical Trial Registry: Searching for Ocular Lubricants, Polyethylene Glycol, and Propylene Glycol
  2. NHS Devon Formulary Guidance: Tear Deficiency, Ocular Lubricants and Astringents
  3. Systematic Review of Polyethylene Glycol-Propylene Glycol Ophthalmic Solutions for Dry Eye Disease

Frequently Asked Questions (FAQ)

Common questions about Tearon (FAQ)

Q: Is Tearon available without a prescription?

A: Yes, Tearon is classified by regulatory agencies as a HUMAN OTC DRUG, which means it is an Over-the-Counter product available for purchase without requiring a prescription. It is regulated for the temporary relief of common dry eye symptoms.

Q: Can Tearon be taken with over-the-counter pain relievers?

A: Tearon is administered topically (as eye drops) and exhibits negligible systemic absorption, meaning very little of the medicine enters the bloodstream. Due to this characteristic, official regulatory documents state that Tearon is not documented to cause systemic drug-drug interactions with other medicines, including over-the-counter systemic pain relievers.

Q: Does Tearon affect contraception or birth control pills?

A: According to official product information, Tearon's topical route of administration results in negligible systemic absorption. Because of this, the drug is not documented to cause systemic drug-drug interactions, which includes interference with hormonal contraceptives or birth control pills.

Q: Is it true that Tearon can interact with certain supplements?

A: Regulatory labeling lists no formal warnings or restrictions regarding interactions with supplements or herbal products. This is because Tearon is a topical medicine with minimal absorption into the body's bloodstream, meaning it does not typically interact with systemic supplements.

Q: Does Tearon interact with caffeine?

A: Official documentation lists no formal warnings or restrictions regarding interactions with food products or beverages like caffeine. This is consistent with the drug's topical administration and negligible systemic absorption.

Q: Is Tearon known to interact with grapefruit?

A: Grapefruit and grapefruit juice are not mentioned in the official labeling as having an interaction risk with Tearon. Regulatory documents state no formal warnings regarding food interactions, which is consistent with a product having negligible systemic absorption.

Q: How long does Tearon take to start working?

A: Tearon is used for the temporary relief of dry eye symptoms. While a specific time-to-onset (e.g., within minutes) is not precisely quantified in official labeling, relief is associated with the physical presence of the lubricating drops on the surface of the eye, consistent with its lubricating function.

Q: Can Tearon affect my ability to drive or operate machinery?

A: Official warnings state that Tearon may cause temporary blurred vision immediately after application. Regulatory guidance states that activities requiring clear vision, such as driving or operating heavy machinery, should be avoided until the temporary blurred vision has cleared.

Q: What should I do if I experience a severe side effect from Tearon?

A: Official labeling instructs the user to stop use and ask a doctor immediately if certain severe or persistent ocular signs develop. These mandated discontinuation criteria include eye pain, changes in vision, or if eye redness or irritation worsens or lasts for more than 72 hours.

Q: Are there any specific activities to avoid while on Tearon?

A: The primary official caution relates to activities requiring clear vision, such as driving or operating machinery, which should be avoided immediately following application due to the possibility of temporary blurred vision. No other specific, general physical restrictions are documented in the official warnings.

Q: Can Tearon be crushed or split?

A: No, Tearon is a liquid Ophthalmic Solution (eye drops). Instructions for crushing or splitting solid dosage forms do not apply to this type of product, which is administered topically to the eye.

Q: Is Tearon the same type of medicine as other treatments for [Condition]?

A: Tearon is officially classified as a lubricant ophthalmic solution, serving as a synthetic tear substitute. This classification means its primary function is to physically lubricate the eye's surface, which differs from the mechanism of action of medicated drops (such as steroids or anti-inflammatories).

Q: What is the difference between Tearon and [Similar Drug Name]?

A: Tearon is defined by its composition, which includes a combination of two active ingredients, Polyethylene Glycol and Propylene Glycol. It is classified as an ocular lubricant and synthetic tear substitute.

Q: Why is Tearon prescribed over other similar medications?

A: Tearon is a combination product containing two active ingredients, Polyethylene Glycol and Propylene Glycol. Studies often examine this dual-polymer system for its potential to provide enhanced lubrication and a longer residence time on the ocular surface compared to some single-polymer formulations.

Q: What distinguishes Tearon from a regular vitamin or supplement?

A: Tearon is regulated as a HUMAN OTC DRUG and is classified as an Ocular Lubricant used for the temporary relief of symptoms. This regulatory classification and intended use distinguish it from products sold and regulated as vitamins or dietary supplements.

Q: Is Tearon safe to take if I have liver problems?

A: Official labeling does not specify dose adjustments or warnings for use in individuals with liver impairment, consistent with its topical use and negligible systemic absorption.

Q: Can I take Tearon if I have a history of heart issues?

A: Official documentation does not list warnings or restrictions specifically for individuals with a history of heart issues, which is consistent with its topical route of administration and negligible systemic absorption.

Q: Does Tearon require special monitoring or blood tests?

A: Due to the topical nature of the product and the lack of documented systemic absorption, the official labeling does not mandate any laboratory monitoring or blood tests during use.

Q: Does Tearon cause weight gain or loss?

A: Systemic side effects, such as changes in body weight, are not listed in the official safety information. This is consistent with Tearon being a topical product with negligible systemic absorption.

Q: Does Tearon make you feel tired or drowsy?

A: Tearon is not documented to cause systemic side effects, such as tiredness or drowsiness, as it has negligible systemic absorption. Adverse reactions are primarily localized to the eye.

Q: Will Tearon affect my energy levels?

A: As a topical product with negligible systemic absorption, Tearon is not documented to cause systemic changes that would affect energy levels.

Q: Does taking Tearon affect my mood?

A: Tearon is a topical product with negligible systemic absorption. Official safety information does not document systemic side effects such as changes in mood.

Q: Is it normal to feel [General symptom, e.g., slightly dizzy] when first starting Tearon?

A: The most common reported adverse reactions are localized to the eye, such as temporary blurred vision, burning, or stinging. Systemic symptoms, such as dizziness, are not generally listed as common side effects.

Q: Does Tearon cause dryness of the mouth or eyes?

A: Tearon is an ocular lubricant intended to relieve dry eye symptoms. Because it is a topical product with negligible systemic absorption, it is not documented to cause systemic side effects, such as dry mouth.

Q: Is Tearon a controlled substance?

A: No, Tearon is not a controlled substance. According to regulatory labeling, its DEA Schedule is listed as None.

Q: Can Tearon cause dependency or withdrawal symptoms?

A: As a topical lubricant that is not a controlled substance, official labeling does not include warnings about physical dependence or withdrawal symptoms. It is used for the symptomatic relief of dry eyes.

Q: Can I stop taking Tearon suddenly, or do I need to taper off?

A: The drug's classification as a non-controlled, topical lubricant means official documents do not include warnings about dependence or the need for a tapering schedule. It is used for the temporary relief of symptoms.

Q: What happens if I miss a dose of Tearon?

A: Since Tearon is directed to be used as needed for the temporary relief of symptoms, official information does not define a 'missed dose' instruction. It is used when symptoms occur, as directed by a healthcare professional.

Q: Are there specific times of day that Tearon should be taken?

A: The official dosing instructions direct the solution to be applied as needed. This means Tearon can be used at any time of day when symptoms of dryness, burning, or irritation occur, with no time-of-day restrictions listed.

Q: Is Tearon meant to be taken short-term or long-term?

A: Tearon is indicated for the temporary relief of symptoms and can be used as needed for acute episodes. It is also suitable for being incorporated into a long-term maintenance regimen under professional guidance, provided symptoms do not persist for more than 72 hours of self-care use.

Q: How long can I expect to take Tearon?

A: Tearon is indicated for the temporary relief of symptoms. Official labeling advises users to stop use and ask a doctor if eye symptoms persist or worsen for more than 72 hours, which sets a limit on the duration of self-care use.

Q: Are there any long-term side effects associated with Tearon?

A: Most clinical studies examining this formulation have been conducted over short-term intervals, typically lasting up to three months. Consequently, the available data for the safety profile over very long-term use (e.g., years) is limited.

Q: Does the efficacy of Tearon change over time?

A: The durability of efficacy (whether the effect changes over time) is not fully established in research. This is because most key research studies focusing on this formulation were conducted over short-term intervals, and long-term data is limited.

Q: Is there a generic version of Tearon available?

A: Yes, the product is sold under many different brands and generic names. This is because the active ingredients, Polyethylene Glycol and Propylene Glycol, are an established combination formula used by many different manufacturers.

Q: What is the typical age range of people who use Tearon?

A: Tearon is officially approved and indicated for use in Adults and Older Adults for temporary dry eye relief. The safety and effectiveness of the product have not been established for use in children under a specified age.

Q: Has Tearon been studied in children or adolescents?

A: The safety and effectiveness of Tearon have not been established in the pediatric population. Official labeling advises that use in children under a specified age should only occur after consultation with a healthcare professional.

Q: Is Tearon part of a wider treatment plan?

A: Tearon is indicated for the temporary relief of symptoms of dry eyes. As an ocular lubricant, its use may be incorporated into a wider management plan for dry eye disease or persistent ocular dryness.

Q: What are the most common reasons why people stop taking Tearon?

A: Official labeling mandates that users stop using the product if they experience certain persistent or worsening ocular signs. These mandatory discontinuation criteria include eye pain, changes in vision, or eye redness or irritation that lasts for more than 72 hours.

How should Tearon be stored and disposed of?

How to Store and Dispose of Tearon

Tearon (Polyethylene Glycol and Propylene Glycol Ophthalmic Solution) must be stored under specific environmental conditions to maintain its labeled stability. The product requires storage at a temperature not exceeding 30°C and must be kept in a cool, dry place and protected from light.

Stability and Handling

To prevent contamination, the user must never touch the tip of the container with any surface and must replace the cap strongly after each use. Once opened, the solution has a restricted shelf-life; it must not be used more than 30 days after the first opening. Tearon must be kept out of the sight and reach of children.

Disposal

Unused or expired product must be disposed of properly by following local and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tearon found in:

A-Z Index: